SUBSCRIBE

Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

Read more breaking news

 

 

Scientists attack proposed EU omega-3 DRVs

By Shane Starling , 16-Oct-2009
Last updated on 19-Oct-2009 at 12:44 GMT2009-10-19T12:44:50Z

Scientists attack proposed EU omega-3 DRVs

An international consortium of concerned lipid scientists says the European Food Safety Authority (EFSA)-recommended omega-3 dietary reference values (DRVs) are seriously flawed and should be amended before they see the light of day in the European Union legislature.

The 22 omega-3 experts said the daily intake recommended level of 250mg was less than half of the 500mg+ daily level recommended by a host of international research groups and government bodies, they said.

In addition, the draft recommendation references plant-sourced ALA (alpha-linolenic acid) as being a viable pre-cursor of EPA (eicosapentaenoic acid) and/or DHA (docosahexaenoic acid), something the scientists vehemently disagree with.

They also criticise the draft for failing to mention omega-3 derived cognitive health benefits.

“EFSA should reconsider its conclusions and advice on omega-3 fatty acids afresh, right from the beginning,” the scientists wrote in an official submission to EFSA.

Now that the public consultation period is closed (as of yesterday), it passes to other arms of the EU for further consideration. The recommendations will act as a reference point for imminent omega-3 labelling rules, the scientists also oppose on similar grounds.

For more on that click here .

DRV debate

The scientists hold the same fundamental position as most of the marine-sourced omega-3 industry, which has been less vocal in its criticism as it has tended to take a pragmatic approach that it is better to have an imperfect rule that can be amended later, than no rule at all.

The industry is of the view that the absence of some kind of guide is more detrimental to business than the imposition of a bottom-of-the-range level, as looks likely. That said, industry lobbying for higher levels continues unabated from the likes of the Global Organization for EPA and DHA (GOED).

“The report will be the foundation for all future EC policies that in any way relate to fats,” said the head of the scientific consortium, Jack Winkler, director of the Nutrition Policy Unit at London Metropolitan University.

He criticised European authorities for scheduling a consultation period over the summer break. None of our members, or their many associates, all well-known specialists in lipids, received any notice of the publication or consultation, nor any request for comment,” he said.

Response in detail

In response to EFSA’s assertion that, "The human body can synthesize EPA and DHA from alpha-linolenic acid", the scientists counteredt: “the conversion rate is so low, especially for DHA, that consumers would receive little or none of the health benefits associated with DHA.”

They noted this was the official position of International Society for the Study of Fatty Acids and Lipids (ISSFAL).

They pointed to mental health benefits from foetal brain development to warding off Alzheimer's disease and recommended US Food and Drug Administration research into “certain neurodevelopmental and cardiovascular endpoints" be tabled.

EFSA should consider the effect of omega-3/omega-6 ratios was also noted, noting increased consumption of omega-6 in western diets was having a detrimental effect on health.

The group of scientists includes Professor Michael Crawford, director of the Institute of Brain Chemistry and Human Nutrition at London Metropolitan University; Peter Clough, technical director at Efamol Limited; Prof Claudio Galli, professor of pharmacology at the University of Milan; and Prof Andrew Sinclair, professor of human nutrition at Deakin University in Australia.

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Fytexia
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Indena
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Capsugel
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Ingredion
Balancing Innovation and Risk in Sports Nutrition Ingredients
NSF-International
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Roquette
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars